- Home
- MCHX vs VTGN Comparison
MCHX vs VTGN Comparison
Compare MCHX & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- VTGN
- Stock Information
- Founded
- MCHX 2003
- VTGN 1998
- Country
- MCHX United States
- VTGN United States
- Employees
- MCHX N/A
- VTGN N/A
- Industry
- MCHX Business Services
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- VTGN Health Care
- Exchange
- MCHX Nasdaq
- VTGN Nasdaq
- Market Cap
- MCHX 84.3M
- VTGN 59.8M
- IPO Year
- MCHX 2004
- VTGN N/A
- Fundamental
- Price
- MCHX $2.13
- VTGN $2.09
- Analyst Decision
- MCHX
- VTGN
- Analyst Count
- MCHX 0
- VTGN 0
- Target Price
- MCHX N/A
- VTGN N/A
- AVG Volume (30 Days)
- MCHX 47.4K
- VTGN 193.9K
- Earning Date
- MCHX 08-07-2025
- VTGN 08-12-2025
- Dividend Yield
- MCHX N/A
- VTGN N/A
- EPS Growth
- MCHX N/A
- VTGN N/A
- EPS
- MCHX N/A
- VTGN N/A
- Revenue
- MCHX $47,951,000.00
- VTGN $486,000.00
- Revenue This Year
- MCHX $5.73
- VTGN N/A
- Revenue Next Year
- MCHX N/A
- VTGN $943.32
- P/E Ratio
- MCHX N/A
- VTGN N/A
- Revenue Growth
- MCHX N/A
- VTGN N/A
- 52 Week Low
- MCHX $1.26
- VTGN $1.90
- 52 Week High
- MCHX $2.40
- VTGN $4.21
- Technical
- Relative Strength Index (RSI)
- MCHX 64.27
- VTGN 39.11
- Support Level
- MCHX $2.11
- VTGN $1.97
- Resistance Level
- MCHX $2.27
- VTGN $2.07
- Average True Range (ATR)
- MCHX 0.13
- VTGN 0.14
- MACD
- MCHX -0.00
- VTGN -0.01
- Stochastic Oscillator
- MCHX 64.71
- VTGN 12.00
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.